Vygon's Qimono vows safe handling of hazardous drugs from vial to vein.
French medical device maker Vygon is seeking to introduce its products to the more countries in the Asia-Oceanic market four years after it opened its Singapore hub. Vygon Asia-Oceanic Regional Director Thanapathy Kumaraiah said the move is in response to the anticipated strong demand for high quality medical and surgical disposables. In particular, the medical solutions firm's ambitious expansion plan includes entering China, Taiwan, South Korea, Indonesia, and Australia. “There is so much demand for Vygon’s wide range of quality medical products due to rise in population, consumer demand, and income growth,” says Kumaraiah.
Starting June this year, Vygon also plans to commence direct sales operations in Singapore. After focusing on paediatrics and neonatology vascular access for preterm babies, Vygon is now hoping that its new high-end products will propel its revenue to new heights.
One of the products it is anchoring its future growth on promises to be a game-changer in Oncology treatments. Vygon's Qimono product range provides a solution to the rising safety concern over Oncology treatments using very aggressive and cytotoxic drugs in the hospital and at home. Qimono solves this risk by handling hazardous drugs at every step, from the vial to the vein, and from the preparation to the waste bin. Because of this, Vygon won Singapore Business Review's International Business Award for Pharmaceuticals.
Vygon's new product combines a male and female connector for completely closed systems. Qimono automatically controls the opening and closing at connection/disconnection on both sides thereby completely isolating the hazardous drugs from the outside. Vygon's new innovative system promises to be an easy-to-use and cost-effective solution for Oncology treatments. Qimono has also been tested to be efficient and compatible with Oncology drugs.
Vygon Vice President for the Asia-Pacific Christophe Deffontaines is also optimistic about the huge role the Qimono product line will play in the company's future growth. “Qimono is expected to be one of the big contributors to Vygon's strategy,” said the Vygon Asia-Pacific VP. "We expect to multiply by three its sales in Asia Pacific by 2022 after already expanding sales by a factor of 2.5 during the last five years.”
The SBR International Business Awards was held on May 17, 2018 at the Conrad Centennial Singapore.
This year's nominations were judged by a panel consisting of Ng Jiak See, executive director and head of corporate finance advisory at Deloitte Singapore & Southeast Asia; Choo Eng Chuan, ASEAN markets leader and partner, international and corporate tax services at Ernst & Young Solutions LLP; Toh Kim Teck, assurance partner at Foo Kon Tan LLP; and Henry Tan, managing director at NEXIA TS.
If you would like to join the 2019 awards and be awarded as one of the most outstanding international companies in Singapore, please email email@example.com.
Do you know more about this story? Contact us anonymously through this link.